Safety, Tolerability, and Immunogenicity of a Booster Dose of Zoster Vaccine, Live (V211-029)

Clinical trial NCT01245751 · COMPLETED

Trial details

NCT number: NCT01245751
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Herpes Zoster Varicella-zoster Vaccine

Start date: 2011-04-01
Primary completion: 2012-07-01
Enrollment: 600

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.